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Abstract
Background: An increasing number of malaria-endemic African countries are rapidly scaling up
malaria prevention and treatment. To have an initial estimate of the impact of these efforts, time
trends in health facility records were evaluated in selected districts in Ethiopia and Rwanda, where
long-lasting insecticidal nets (LLIN) and artemisinin-based combination therapy (ACT) had been
distributed nationwide by 2007.
Methods:  In Ethiopia, a stratified convenience sample covered four major regions where
(moderately) endemic malaria occurs. In Rwanda, two districts were sampled in all five provinces,
with one rural health centre and one rural hospital selected in each district. The main impact
indicator was percentage change in number of in-patient malaria cases and deaths in children < 5
years old prior to (2001–2005/6) and after (2007) nationwide implementation of LLIN and ACT.
Results: In-patient malaria cases and deaths in children < 5 years old in Rwanda fell by 55% and
67%, respectively, and in Ethiopia by 73% and 62%. Over this same time period, non-malaria cases
and deaths generally remained stable or increased.
Conclusion: Initial evidence indicated that the combination of mass distribution of LLIN to all
children < 5 years or all households and nationwide distribution of ACT in the public sector was
associated with substantial declines of in-patient malaria cases and deaths in Rwanda and Ethiopia.
Clinic-based data was a useful tool for local monitoring of the impact of malaria programmes.
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Background
In 2005, the global malaria community committed itself
to the goal of reducing the global malaria burden by at
least 50% by 2010 [1]. The recommended method to
achieve this target is > 80% coverage of the four main
malaria control tools: long-lasting insecticide treated bed
nets (LLIN), indoor residual spraying (IRS), intermittent
presumptive treatment of pregnant women (IPT), and
treatment with effective medicines, principally artemisi-
nin-based combination therapy (ACT).
Starting from a low baseline in 2005 [2], countries are
now engaged in efforts at rapid scale-up to reach the 2010
coverage targets. This scale-up to achieve disease-control
targets raises several questions. What is the causal rela-
tionship between the coverage targets and the disease con-
trol goals: does 50% disease reduction require 80%
coverage of all interventions or can partial coverage of
selected interventions more efficiently achieve the goal ?
How rapid is the impact seen after scale-up ? How can
impact be measured – can one use existing data in the
public health system or are special surveys required ? To
address these questions, the impact of malaria control on
health facility burdens was assessed in selected areas of
Rwanda and Ethiopia, two countries that had recently
conducted national scale-up of the distribution of LLIN
and use of ACT.
Methods
Data were collected during two weeks in November–
December 2007 by Ministry of Health and WHO person-
nel.
Interventions
In Rwanda, the Ministry of Health (MOH) introduced
LLIN and ACT nationwide within a two-month period,
September to October 2006. In September 2006, the
MOH conducted a mass distribution of 1.96 million LLIN
to children < 5 years, integrated with measles vaccination.
(In comparison, Rwanda's population was around 9.5
million in 2006.) During a household survey 8 months
after this campaign, LLIN use in children < 5 years old was
60% (unpublished MOH Malaria Indicator Survey,
2007). ACT was introduced nationwide quickly in Octo-
ber 2006 to public-sector health facilities throughout the
country.
In Ethiopia, the MOH conducted continuous mass distri-
bution of LLIN from September 2005 to December 2007,
aiming to distribute one LLIN per two persons at risk. In
2005–2006, 16.3 million LLIN were received, and all
except 2.2 million were distributed nationwide by end of
2007 [3]. ACT were first distributed in the public sector in
2005. Over 2005–6, 10.2 million ACT courses were dis-
tributed. In comparison, the national population of Ethi-
opia was 81 million in 2006, out of which 55 million
people were living in areas with (stable or unstable)
malaria transmission. Results from a Malaria Indicator
Survey conducted in October to December 2007 indicated
that 65% of households in areas < 2000 meters elevation
had at least one LLIN [3].
Selection of districts
To evaluate intervention effect on malaria morbidity and
mortality burden in both Ethiopia and Rwanda, districts
were selected with two main objectives: areas with stable
Plasmodium falciparum malaria transmission and achieve-
ment of wide geographical representation.
In Ethiopia, two districts were conveniently selected from
each of four major Regions than have areas with moderate
malaria: Oromiya; Southern Nations, Nationalities, and
Peoples (SNNP); Amhara; and Tigray.
In Rwanda, two districts in all five provinces were sam-
pled, hence covering 10 of 33 districts.
Selection of health facilities
Figures 1 and 2 show the location of selected facilities
with complete data in both countries. Per selected district,
one hospital and one out-patient health center were sam-
pled. In Ethiopia, facilities with complete data were
spread over approximately half the country (Figure 1). In
Rwanda, facilities with complete data were spread
throughout the country (Figure 2).
In Rwanda, one health center was excluded from analysis
because of incomplete data, leaving nine out of the total
national 39 hospitals, and 10 out of the 439 national
health centers in the sample. All sampled facilities per-
formed malaria smears on all suspected malaria cases, and
the out-patient cases that were analysed represent exclu-
sively laboratory-confirmed cases.
In Ethiopia, health facilities that did not have data going
back to 2001 were excluded. Some health facilities had
complete data for some age groups (for example, total for
all ages, but not < 5 years). Five health facilities had com-
plete in-patient data for both cases and deaths for all ages
(total), four facilities had in-patient case data by age group
(< 5 and ≥ 5 years), and three facilities had in-patient
death data by age group. Complete out-patient data was
available from eight facilities for all ages combined, and
from seven facilities by age group. For Ethiopia, the pro-
portion of out-patient cases that had laboratory examina-
tions was not recorded.
Data and indicators analysed
Interviewers abstracted data either from health-facility
copies of national surveillance forms, other health infor-Malaria Journal 2009, 8:14 http://www.malariajournal.com/content/8/1/14
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mation forms, or from patient registers. At least two per-
sons visited each district for at least two days. Monthly
data between January 2001 and November 2007 were
abstracted. From hospitals, data on in-patient malaria and
all-cause cases and deaths, and from out-patient health
centers and hospital out-patient departments, data on lab-
oratory-confirmed out-patient malaria cases and all-cause
attendances were collected. For all indicators, data were
stratified in two age groups, < 5 years and ≥ 5 years, as far
as available.
For facilities which had one or two months of data miss-
ing in a year, data were imputed as the average of the
month prior and month after the month(s) of missing
data. In Ethiopia, in-patient data was imputed for 15 of
586 health-facility-months. In Rwanda, out-patient data
were imputed for 55 of 1,595 health-facility-months and
in-patient data for 1 of 133 facility-years.
Evaluation of time trends and intervention impact
To assess changes in indicators associated with the scale-
up of LLIN and ACT, numbers of malaria and non-malaria
cases and deaths were compared between years before
LLIN and ACT introduction, and the year thereafter.
Analyses were limited for all years to January to October
because October 2007 was the last month with complete
data in both countries. In Ethiopia, 2001–2005 as the ref-
erence period was used because most LLIN and ACT were
distributed in September 2005 or later, so these interven-
tions would not have much effect on data from January to
October 2005. The years 2001–2006 were used as the ref-
erence period for Rwanda, where interventions were
scaled-up in September–October 2006.
Two methods were used to estimate the decline in malaria
cases and deaths after intervention. First, 2007 data were
compared with the average of the pre-intervention period
(2001–2006 for Rwanda and 2001–2005 for Ethiopia;
Table 1, column 5 for malaria and column 9 for non-
malaria).
The second method accounted for possible time trends in
indicators that started before the interventions and would
Location of hospitals and health centers that were selected for data collection and had complete data for 2001–2007, Novem- ber 2007, Ethiopia Figure 1
Location of hospitals and health centers that were selected for data collection and had complete data for 
2001–2007, November 2007, Ethiopia.Malaria Journal 2009, 8:14 http://www.malariajournal.com/content/8/1/14
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thus be unrelated to the interventions – such as popula-
tion growth, improved health facility access and attend-
ance. Here, the observed 2007 value for each indicator
was compared with its corresponding, expected value for
that year based on the linear trend over 2001 through
2005/6 (using SPSS Inc., version 14.0 for linear regres-
sions and 2-tailed Student's T-tests for assessing statistical
significance of the difference between observation and
expectation). In this second analysis, any decreases in
malaria indicators observed in 2007 which could be pre-
dicted simply from a trend of decline in that indicator
over preceding years were thus not attributed to the inter-
ventions, whereas decreases larger than those apparent
over previous years and decreases that started in 2007
were attributed to the interventions.
For Rwanda, in addition, the month-to-month trend in
malaria slide positivity rate was analysed (including all 12
months of all calendar years), alongside the month-to-
month trends in out-patient malaria laboratory-con-
firmed cases, in-patient malaria cases, and non-malaria
inpatient cases.
Results
Time patterns of intervention scale-up and start of health 
facility impact
Figures 3 and 4 show the time trends in in-patient malaria
and non-malaria cases in children < 5 years by calendar
year. For both countries, declines in malaria indicators
were apparent that started within a year after scale-up of
LLIN and ACT.
In Rwanda (Figure 3), the decline observed in 2007 was
very sharp and distinct, following a trend of moderate
increase in malaria cases over 2001–5. Non-malaria cases
increased throughout 2001 to 2007, possibly indicating a
general trend of improving health facility access and
attendance – not related to malaria intervention – over
this period.
Data for Ethiopia (Figure 4) also showed a marked decline
in malaria cases in 2007 (possibly starting in 2006). Here,
however, the causal relationship with the scale-up of LLIN
and ACT was less obvious than in Rwanda, because of
marked fluctuation in malaria cases over the pre-interven-
tion period 2001–2005. Non-malaria cases in Ethiopia
also fluctuated considerably from year to year, with per-
haps a slight overall increase over 2001–2007.
Rwanda
Comparing 2007 against the average of 2001–2006,
observed declines in the two age groups ranged from 52%
to 67% among the three malaria indicators, except for in-
patient malaria deaths in those ≥ 5 years which declined
by only 10% (Table 1, column 5). Declines in children <
5 years old were 55% for in-patient malaria cases, 67% for
in-patient malaria deaths, and 58% for out-patient labo-
ratory-confirmed cases.
Adjusting for pre-intervention trends, the estimated
declines in the two age groups ranged from 54% to 68%
for the three indicators, and these were all highly signifi-
cant (Table 1, column 6). An exception was in-patient
malaria deaths in those ≥ 5 years, for which the decline
was estimated as a non-significant 8%. Since most malaria
indicators had slightly increased between 2001 and 2006,
this adjustment slightly increased the estimated impact in
children < 5 years old, to declines of 64% for in-patient
malaria cases, 68% for in-patient malaria deaths, and 63%
for out-patient laboratory confirmed cases.
Non-malaria out-patient cases and in-patient cases and
deaths, in contrast, were all higher (by 17% to 75%) in
2007 compared to the average over 2001–2006 (Table 1,
column 9). For none of the non-malaria indicators was
the observed value in 2007 statistically different from that
expected based on the trend of increase over 2001–2006
(Table 1, column 10).
Rwanda was unique because nationwide distribution of
LLIN and ACT occurred within only 60 days in Septem-
ber–October 2006. As an obvious effect, the monthly
number of malaria cases showed a sharp immediate
decline in November and December of that year (Figure
5).
As an additional analysis adjusting for month-to-month
fluctuations, the malaria slide positivity rate, in-patient
malaria cases and out-patient malaria laboratory-con-
firmed cases all showed highly significant reductions (p <
Location of hospitals and health centers that were selected  for data collection and had complete data, December 2007,  Rwanda Figure 2
Location of hospitals and health centers that were 
selected for data collection and had complete data, 
December 2007, Rwanda.Malaria Journal 2009, 8:14 http://www.malariajournal.com/content/8/1/14
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0.001) in 2007 compared to 2001–6. In contrast, the
number of non-malaria in-patient cases was not signifi-
cantly different in 2007 compared to 2001–6 (p = 0.74),
when adjusting for month-to-month fluctuations.
Ethiopia
Comparing 2007 against the average of 2001–2006,
observed declines ranged from 62% to 85% among the
three malaria indicators in the two age groups (Table 1,
column 5). Observed declines in children < 5 years old
were 73% for in-patient malaria cases, 62% for in-patient
malaria deaths, and 85% for out-patient laboratory-con-
firmed cases.
Adjusting for pre-intervention trends, the estimated
declines in the two age groups ranged from 3% to 91%
across the eight malaria indicators and age groups for
which statistical testing was possible, with seven out of
eight effects being statistically significant (Table 1, col-
umn 6). For in-patient deaths in children under five years
of age, too few data points were available to allow statisti-
cal testing.
In comparison, non-malaria out-patient cases and in-
patient cases and deaths were higher (by 1% to 45%) in
2007 compared to the average of 2001–2006, except for
in-patient deaths which declined by 13% for those <5
years and 31% for those ≥ 5 years (Table, column 9). After
adjustment for trends over 2001–2006, non-malaria in-
patient cases declined significantly by 11–25%, while out-
patient cases increased in children under-five, but
decreased in the age group over five years (Table 1, col-
umn 10). For in-patient deaths, no significant changes
were apparent in 2007, when adjusting for prior time
trends.
Discussion
This study documents for the first time marked reductions
in malaria cases and deaths in health facilities in two
medium- and large-sized countries following large-scale
Table 1: Percentage change in malaria and non-malaria cases and deaths in 2007 compared to pre-intervention reference period, in 
selected health facilities, in persons < 5 years and ≥ 5 years, Ethiopia and Rwanda, from January to October each year. Positive 
percentage indicates decline, negative percentage indicates an increase.
MALARIA NON-MALARIA
Indicator Age (years) Annual average, 
reference 
period
2007 Decline in 2007 Annual average, 
reference 
period
2007 Decline in 2007
Observed, 
compared to 
average over 
2001–5/6*
Adjusted for 
linear trend over 
2001–5/6† 
(95% CI)
Observed, 
compared to 
average over 
2001–5/6*
Adjusted for 
linear trend over 
2001–5/6† 
(95% CI)
Rwanda
In-patient cases < 5 7,686 3,473 55% 64% (60–68)‡ 6,043 7,793 -29% 9% (-7 – 20)
5+ 10,250 4,403 57% 59% (53–64)‡ 27,384 45,275 -65% -7% (-20 – -3)
All 17,936 7,876 56% 61% (57–65)‡ 33,427 53,068 -59% -5% (-17 – -6)
In-patient 
deaths
< 5 153 51 67% 68% (56–75)‡ 221 259 -17% 4% (-20 – 21)
5+ 207 187 10% 8% (-32 – 29) 644 939 -46% -10%(-30 – -6)
All 360 238 34% 34% (9–48)‡ 865 1,198 -39% -6% (-27 – -9)
Laboratory-
confirmed out-
patient cases
< 5 11,216 4,665 58% 63% (55–68)‡ 38,996 61,108 -57% 4% (-7 – 13)
5+ 19,221 9,254 52% 54% (39–62)‡ 120,587 210,644 -75% 3% (-5 – 10)
All 30,437 13,919 54% 57% (46–64)‡ 159,583 271,752 -70% 4% (-5 – 11)
Ethiopia
In-patient cases < 5 866 232 73% 83% (79–86)‡ 1,140 1,245 -9% 25% (20 – 30)‡
5+ 3,381 1,093 68% 69% (6–82)‡ 5,993 7,968 -33% 11% (4 – 16)‡
All 4,540 1,357 70% 75% (51–84)‡ 7,263 9,391 -29% 14% (8 – 19)
In-patient 
deaths
< 5 11 4 62% Too few data 23 20 13% Too few data
5+ 28 7 75% 3% 
(-103 – 54%)
65 45 31% -117% 
(-150 – -71)
All 135 28 79% 84% (67–89)‡ 294 408 -39% -10% 
(-24 – -2)
Laboratory-
confirmed out-
patient cases
< 5 5,495 801 85% 69% (45–83%)‡ 30,228 43,688 -45% -15% (-30 – -3)‡
5+ 17,903 2,841 84% 91% (87–93)‡ 160,339 162,565 -1% 20% (12 – 26)‡
All 31,493 6,131 81% 85% (77–89)‡ 184,777 209,244 -13% 4% (-7 – 12)
* Reference period was 2001–2006 for Rwanda and 2001–2005 for Ethiopia
† Percentage change was calculated by comparing reported number of cases/deaths in 2007 with predicted number of cases/deaths in 2007 based on linear trend of 2001 to 
2005/6.
‡ Significant difference. A 95% CI not including the 0% value indicates that the difference in 2007 compared to the pre-intervention period was statistically significant 
(p < 0.025).Malaria Journal 2009, 8:14 http://www.malariajournal.com/content/8/1/14
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distribution of LLIN and ACT. In particular in children
under-five, declines of malaria cases and deaths were dra-
matic (~50% or higher), and occurred within one year of
the scale-up of malaria interventions. This suggests that
mass distribution of LLIN and nationwide roll-out of ACT
conducted within months of the start of an expected
malaria season may reduce cases and deaths during that
transmission season.
In both Rwanda and Ethiopia, declines were of similar
magnitude (~50% or higher) for in-patient cases and
deaths, and out-patient laboratory-confirmed malaria
cases. In Rwanda, all suspected malaria cases had labora-
tory examination. Since laboratory-confirmed diagnosis
has better specificity for malaria than clinical diagnosis
[4], this similarity supports the interpretation that appar-
ent impacts are real, rather than being artifacts of chang-
ing patterns of diagnostic practices in the sampled
facilities.
In Rwanda, the decline of in-patient and out-patient lab-
oratory-confirmed malaria cases occurred in the face of
increases in in-patient and out-patient non-malaria cases
over 2001–2005, which probably reflected the introduc-
tion of health insurance schemes, resolution of civil con-
flict, and improvement of health services. The
exceptionally low percentage decline in in-patient malaria
deaths in Rwandans ≥ 5 years old was due to the doubling
of reported malaria deaths in a single hospital (Nyanza)
in the year 2007 (51 deaths, compared to < 25 annual
malaria deaths during 2001–2006). As also non-malaria
deaths in Nyanza hospital increased by 54% in 2007 com-
pared to 2001–5, this sudden increase may relate to non-
malaria factors. In any case, numbers of malaria deaths
analysed (in both Rwanda and Ethiopia) were small,
resulting in wide uncertainty ranges around mortality
impact estimates.
In Ethiopia the strength of evidence was limited, first, by
the small number of facilities with complete data for both
age groups starting in 2001. Whereas the original sample
had covered 13 out-patient and seven in-patient health
facilities, only eight out-patient and five in-patient facili-
ties had complete data over the period 2001–2007 (for at
least all-ages combined) allowing inclusion in the present
analysis. More fundamentally, the unstable nature of
malaria transmission in Ethiopia [5] and the large year-to-
year fluctuations in health facility burdens, also for non-
malaria cases and deaths (Figure 4), make it impossible to
draw firm conclusions yet regarding the causal relation-
ship between the observed malaria declines and LLIN and
ACT scale-up. Of note, Ethiopia experienced marked epi-
Malaria and non-malaria in- and out-patient cases, children < 5 years old, January to October 2001–2007, Rwanda Figure 3
Malaria and non-malaria in- and out-patient cases, children < 5 years old, January to October 2001–2007, 
Rwanda. LLIN = long-lasting insecticidal nets, ACT = artemisinin-based combination therapy medicines.Malaria Journal 2009, 8:14 http://www.malariajournal.com/content/8/1/14
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demics in 2003–4 [6,7], after which declines in malaria
indicators were expected even in the absence of interven-
tion impact. Nevertheless, a repeat of the current analysis
with a few additional years of post-intervention data
could be expected to yield conclusive evidence as to the
impact of the national LLIN and ACT scale-up.
The magnitudes of declines found in malaria indicators
are in line with those reported from similar studies in
small-scale areas of Kenya and Zanzibar. In three hospitals
along the Kenya coast, in-patient pediatric malaria cases
declined 28–63% as of March 2007, after distributions of
ITNs and ACT [8]. In District A in Zanzibar, in-patient
malaria cases and deaths in children declined by 77% and
75%, respectively, within 24 months after the introduc-
tion of ACT in all 13 health facilities (and prior to sub-
stantial distribution of LLIN) [9].
The limitations were the following. Districts and health
facilities were not randomly selected, but constituted a
(stratified) convenience sample, selecting those sites
where intervention scale-up had been relatively rapid and
successful and where health facility data were of relatively
good quality (e.g., in Ethiopia, excluding facilities where
records did not go back to 2001). Therefore, estimated
impacts cannot be extrapolated to the countries nation-
wide. Also, while these results illustrate the benefits of
rapid scale-up in the populations sampled, it would be
inappropriate to extrapolate these findings to other coun-
tries with more intense malaria transmission, where inter-
ventions at similar coverage levels may have lower impact.
A more general limitation of health facility data is that
they cover only the cases and deaths of patients who
accessed the (public) health care system. Especially for
ACT, it is possible that their coverage and impact is largely
limited to the catchment populations of the facilities pro-
viding these drugs – with population-level impact dimin-
ishing by distance from health facilities. For this reason, it
is difficult to extrapolate the observed health facility
impacts to effects for the full populations living in the dis-
tricts sampled. Inferences about population-level disease
impact will typically require triangulation of several
sources of data, including data from household surveys
[10].
Malaria and non-malaria in- and out-patient cases, children < 5 years old, January to October 2001–2007, Ethiopia Figure 4
Malaria and non-malaria in- and out-patient cases, children < 5 years old, January to October 2001–2007, Ethi-
opia. LLIN = long-lasting insecticidal nets, ACT = artemisinin-based combination therapy medicines.Malaria Journal 2009, 8:14 http://www.malariajournal.com/content/8/1/14
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Third, in Ethiopia, indoor residual spraying (IRS) has
been a well-established vector control intervention for a
long period. It is applied in a focalized manner by target-
ing villages at risk for malaria epidemics. All districts vis-
ited had been applying IRS in a limited way during much
of 2001–2007. The contribution of IRS to declines could
not be estimated since IRS activities occurred throughout
both pre- and post-intervention period.
Evaluation of impact is an essential part of modern pro-
gramme management practice and will be needed by all
high-burden African countries to meet the Roll Back
Malaria goal of > 50% reduction in malaria-related mor-
tality by 2010. Health facility data are important for
quickly and continuously monitoring interventions with
high impact at the health facility and district level. Facil-
ity-based surveillance may become even more important
in the future, once wide-scale use of LLIN and ACT may
change the epidemiology of malaria from stable endemic
to unstable/epidemic. Areas of unstable and highly sea-
sonal malaria will need to rely on continuous, timely sur-
veillance to detect and respond to epidemics.
In conclusion, these initial data suggest that widespread
distribution of LLIN and use of ACT in the public sector
can result in marked reductions in the burden of non-
severe and severe malaria morbidity and mortality seen in
public-sector health facilities. International partners
should urgently collaborate with national governments to
ensure that all at-risk persons have access to appropriate
vector control, including LLIN, and treatment with ACT.
The magnitude of declines (≥ 50%) found in the studied
facilities of Rwanda and Ethiopia was similar to that
needed – at a population level – to reach the RBM target
of 50% mortality reduction by 2010. It appears that
marked reduction in malaria mortality can be achieved
quickly and detected within a short time of scaling-up
interventions, which may enable many African countries
to make rapid progress towards the child survival targets
in the Millennium Development Goals.
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